# Transcontinental Realty Investors Inc: financial statements, quarterly

TCI · NYSE · CIK 733590 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tci.md) · [Financials](/companies/tci/financials.md) · [Filings](/companies/tci/filings.md) · [Insiders](/companies/tci/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/tci/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [12.5](/filings/0000733590-25-000004.md) | [13.5](/filings/0000733590-25-000004.md) | [11.9](/filings/0000733590-26-000004.md) | [11.8](/filings/0000733590-26-000004.md) | [11.6](/filings/0000733590-26-000004.md) | [11.8](/filings/0000733590-26-000004.md) | [12.0](/filings/0001628280-26-031845.md) | [12.2](/filings/0001628280-26-054111.md) | [12.8](/filings/0000733590-26-000004.md) | [12.1](/filings/0000733590-26-000004.md) | [12.3](/filings/0001628280-26-031845.md) | [12.9](/filings/0001628280-26-054111.md) |
| Operating income | $m | [(1.8)](/filings/0000733590-25-000004.md) | [(2.1)](/filings/0000733590-25-000004.md) | [(1.3)](/filings/0000733590-26-000004.md) | [(1.1)](/filings/0000733590-26-000004.md) | [(1.7)](/filings/0000733590-26-000004.md) | [(1.7)](/filings/0000733590-26-000004.md) | [(0.6)](/filings/0001628280-26-031845.md) | [(0.8)](/filings/0001628280-26-054111.md) | [(1.4)](/filings/0000733590-26-000004.md) | [(3.5)](/filings/0000733590-26-000004.md) | [(2.0)](/filings/0001628280-26-031845.md) | [(2.3)](/filings/0001628280-26-054111.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.3](/filings/0000733590-24-000020.md) | [(0.7) d](/filings/0000733590-26-000004.md) | [0.6](/filings/0000733590-25-000010.md) | [0.7](/filings/0000733590-25-000017.md) | [0.5](/filings/0000733590-25-000029.md) | [0.1 d](/filings/0000733590-26-000004.md) | [1.3](/filings/0001628280-26-031845.md) | [2.0](/filings/0001628280-26-054111.md) | [1.6](/filings/0000733590-25-000029.md) | [2.1 d](/filings/0000733590-26-000004.md) | [(0.4)](/filings/0001628280-26-031845.md) | [(0.1)](/filings/0001628280-26-054111.md) |
| Net income | $m | [4.5](/filings/0000733590-25-000004.md) | [(2.6)](/filings/0000733590-25-000004.md) | [2.5](/filings/0000733590-26-000004.md) | [1.5](/filings/0000733590-26-000004.md) | [1.7](/filings/0000733590-26-000004.md) | [0.1](/filings/0000733590-26-000004.md) | [4.6](/filings/0001628280-26-031845.md) | [0.2](/filings/0001628280-26-054111.md) | [0.7](/filings/0000733590-26-000004.md) | [8.3](/filings/0000733590-26-000004.md) | [0.2](/filings/0001628280-26-031845.md) | [(1.1)](/filings/0001628280-26-054111.md) |
| Diluted EPS | $ per share | [0.52](/filings/0000733590-25-000004.md) | [(0.30)](/filings/0000733590-25-000004.md) | [0.30](/filings/0000733590-26-000004.md) | [0.17](/filings/0000733590-26-000004.md) | [0.20](/filings/0000733590-26-000004.md) | [0.01](/filings/0000733590-26-000004.md) | [0.53](/filings/0001628280-26-031845.md) | [0.02](/filings/0001628280-26-054111.md) | [0.08](/filings/0000733590-26-000004.md) | [0.97](/filings/0000733590-26-000004.md) | [0.02](/filings/0001628280-26-031845.md) | [(0.13)](/filings/0001628280-26-054111.md) |
| Basic EPS | $ per share | [0.52](/filings/0000733590-25-000004.md) | [(0.30)](/filings/0000733590-25-000004.md) | [0.30](/filings/0000733590-26-000004.md) | [0.17](/filings/0000733590-26-000004.md) | [0.20](/filings/0000733590-26-000004.md) | [0.01](/filings/0000733590-26-000004.md) | [0.53](/filings/0001628280-26-031845.md) | [0.02](/filings/0001628280-26-054111.md) | [0.08](/filings/0000733590-26-000004.md) | [0.97](/filings/0000733590-26-000004.md) | [0.02](/filings/0001628280-26-031845.md) | [(0.13)](/filings/0001628280-26-054111.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [47.2](/filings/0000733590-24-000020.md) | [36.7](/filings/0000733590-26-000004.md) | [54.7](/filings/0000733590-25-000010.md) | [46.0](/filings/0000733590-25-000017.md) | [39.5](/filings/0000733590-25-000029.md) | [19.9](/filings/0000733590-26-000004.md) | [13.8](/filings/0000733590-25-000010.md) | [15.4](/filings/0000733590-25-000017.md) | [11.9](/filings/0000733590-25-000029.md) | [14.1](/filings/0001628280-26-054111.md) | [9.5](/filings/0001628280-26-031845.md) | [10.7](/filings/0001628280-26-054111.md) |
| Total assets | $m | [1,080](/filings/0000733590-23-000020.md) | [1,043](/filings/0000733590-25-000004.md) | [1,042](/filings/0000733590-24-000011.md) | [1,047](/filings/0000733590-24-000016.md) | [1,057](/filings/0000733590-24-000020.md) | [1,071](/filings/0000733590-26-000004.md) | [1,084](/filings/0000733590-25-000010.md) | [1,127](/filings/0000733590-25-000017.md) | [1,134](/filings/0000733590-25-000029.md) | [1,133](/filings/0001628280-26-054111.md) | [1,129](/filings/0001628280-26-031845.md) | [1,130](/filings/0001628280-26-054111.md) |
| Total liabilities | $m | [230](/filings/0000733590-23-000020.md) | [196](/filings/0000733590-25-000004.md) | [193](/filings/0000733590-24-000011.md) | [196](/filings/0000733590-24-000016.md) | [204](/filings/0000733590-24-000020.md) | [218](/filings/0000733590-26-000004.md) | [227](/filings/0000733590-25-000010.md) | [270](/filings/0000733590-25-000017.md) | [277](/filings/0000733590-25-000029.md) | [266](/filings/0001628280-26-054111.md) | [262](/filings/0001628280-26-031845.md) | [265](/filings/0001628280-26-054111.md) |
| Long-term debt | $m | [179](/filings/0000733590-23-000020.md) | [179](/filings/0000733590-25-000004.md) | [178](/filings/0000733590-24-000011.md) | [177](/filings/0000733590-24-000016.md) | [180](/filings/0000733590-24-000020.md) | [182](/filings/0000733590-26-000004.md) | [198](/filings/0000733590-25-000010.md) | [212](/filings/0000733590-25-000017.md) | [223](/filings/0000733590-25-000029.md) | [211](/filings/0001628280-26-054111.md) | [212](/filings/0001628280-26-031845.md) | [214](/filings/0001628280-26-054111.md) |
| Shareholders' equity | $m | [828](/filings/0000733590-23-000020.md) | [826](/filings/0000733590-25-000004.md) | [829](/filings/0000733590-24-000011.md) | [830](/filings/0000733590-24-000016.md) | [832](/filings/0000733590-24-000020.md) | [832](/filings/0000733590-26-000004.md) | [837](/filings/0000733590-25-000010.md) | [838](/filings/0000733590-25-000017.md) | [838](/filings/0000733590-25-000029.md) | [847](/filings/0001628280-26-054111.md) | [847](/filings/0001628280-26-031845.md) | [846](/filings/0001628280-26-054111.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.3 d](/filings/0000733590-24-000020.md) | [(38.9) d](/filings/0000733590-26-000004.md) | [3.9](/filings/0000733590-25-000010.md) | [(0.5) d](/filings/0000733590-25-000017.md) | [13.7 d](/filings/0000733590-25-000029.md) | [(15.7) d](/filings/0000733590-26-000004.md) | [(7.4)](/filings/0001628280-26-031845.md) | [(2.9) d](/filings/0001628280-26-054111.md) | [8.2 d](/filings/0000733590-25-000029.md) | [(0.7) d](/filings/0000733590-26-000004.md) | [(2.9)](/filings/0001628280-26-031845.md) | [(2.4) d](/filings/0001628280-26-054111.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,639](/filings/0000733590-23-000020.md) | [8,639](/filings/0000733590-24-000011.md) | [8,639](/filings/0000733590-24-000016.md) | [8,639](/filings/0000733590-24-000020.md) | [8,639](/filings/0000733590-25-000010.md) | [8,639](/filings/0000733590-25-000017.md) | [8,639](/filings/0000733590-25-000029.md) | [8,639](/filings/0001628280-26-031845.md) | [8,639](/filings/0001628280-26-054111.md) | [8,639](/filings/0000733590-25-000029.md) | [8,639](/filings/0001628280-26-031845.md) | [8,639](/filings/0001628280-26-054111.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,773,965 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054111.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.